Alina Elena Parvu | Medicinal Plants | Excellence in Research award

Published on by Plant Scientist

Prof. Alina Elena Parvu | Medicinal Plants | Excellence in Research award

University of Medicine and Pharmacy ‘Iuliu Hatieganu” Cluj-Napoca | Romania

Prof. Alina Elena Pârvu is a distinguished academic and researcher at the University of Medicine and Pharmacy “Iuliu Hațieganu”, Cluj-Napoca, Romania. She holds advanced qualifications in biomedical sciences and has extensive experience in teaching and research. Her work focuses on molecular biology, experimental medicine, pharmacology, and the therapeutic potential of natural compounds. She has contributed to numerous scientific publications and collaborative research projects, advancing knowledge in oxidative stress, inflammation, and metabolic disorders. Recognized for her scientific contributions and academic leadership, she continues to mentor young researchers and promote innovation in medical science and translational research.

                           Citation Metrics (Scopus)

4000
3000
2000
1000
100
0

Citations
2122

Documents
111

h-index
24

Citations

Documents

h-index

View Scopus Profile
    View Google Scholar

Featured Publications

Elisa Buzzatti | Medicine | Research Excellence Award

Published on by Plant Scientist

Dr. Elisa Buzzatti | Medicine | Research Excellence Award

University Tor Vergata | Italy

Elisa Buzzatti is a physician–scientist and hematologist with advanced training in medical biotechnology and translational medicine. She earned her medical degree and specialization in Hematology at the University of Rome “Tor Vergata” and is currently enrolled in a doctoral program in Medical Biotechnology and Translational Medicine. Her clinical and research experience spans stem cell transplantation, acute and chronic leukemias, myeloproliferative disorders, and phase II–III clinical trials. She has contributed to numerous high-impact, peer-reviewed international publications and multicenter studies. Her research focuses on leukemia biology, immunotherapy, infectious complications, and measurable residual disease, aiming to improve precision and outcomes in hematologic malignancies.

                    Citation Metrics (Scopus)

400

300

200

100

10

0

 

Citations
241
Documents
35
h-index
10

Citations

Documents

h-index

View Scopus Profile   View Google Scholar Profile

Featured Publications